The mechanism of action, pharmacological characteristics, and clinical utility of the amyloid depleter birtamimab for the potential treatment of AL amyloidosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The mechanism of action, pharmacological characteristics, and clinical utility of the amyloid depleter birtamimab for the potential treatment of AL amyloidosis

Published:2024-04-11 Issue:8 Volume:65 Page:1068-1078
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Palladini Giovanni¹²,Liedtke Michaela³,Zago Wagner⁴,Dolan Phil⁴,Kinney Gene G.⁴,Gertz Morie A.⁵^ORCID

Affiliation:

1. Department of Molecular Medicine, University of Pavia, Pavia, Italy

2. Amyloidosis Research and Treatment Center, Fondazione IRCCS, Policlinico San Matteo, Pavia, Italy

3. Stanford Cancer Institute, Stanford, CA, USA

4. Prothena Biosciences Inc, Brisbane, CA, USA

5. Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA

Funder

Prothena Biosciences, Ltd

Prothena Biosciences, Ltd, Dublin, Ireland

Prothena Corporation plc group

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2024.2337803

Reference88 articles.

1. Immunoglobulin light-chain amyloidosis: clinical presentations and diagnostic approach;Hwa YL;J Adv Pract Oncol,2019

2. AL amyloidosis: from molecular mechanisms to targeted therapies

3. Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update

4. Recent Advances in the Diagnosis, Risk Stratification, and Management of Systemic Light-Chain Amyloidosis

5. Global epidemiology of amyloid light-chain amyloidosis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP